Insiders who reported open-market trades in the last 12 months at the companies Steve E. Krognes files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Amirali Talasaz - $73.75M in GH purchases and sales in the last 12 months
Terilyn J. Monroe - $14.82M in GH purchases and sales in the last 12 months
Chris Freeman - $13.68M in GH purchases and sales in the last 12 months
Helmy Eltoukhy - $12.63M in GH purchases and sales in the last 12 months
Kumud Kalia - $5.78M in GH purchases and sales in the last 12 months
John G. Saia - $4.25M in GH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Steve E. Krognes is a corporate insider, tracked as Director of Guardant Health, Inc. (GH). InsiderAlpha holds 21 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Steve E. Krognes submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Steve E. Krognes been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($3.28M) across all tracked filings.
Steve E. Krognes is Director of Guardant Health, Inc. (GH). 21 SEC Form 4 filings on record going back to 2024, most recently on 17 September 2026. Most recent open-market trade: sold $172K of GH on 17 September 2026. Lifetime open-market sales: $3.28M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Steve E. Krognes.
InsiderAlpha's records for Steve E. Krognes go back to 2024: 21 primary Form 4 filings, an average of 7.0 per year. 1 recorded transaction carries a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
